About Us   Founded in 2014, Deep Genomics is a drug development company that aims to revolutionize medicine by leveraging expertise in artificial intelligence (AI) and genome biology. With additional locations in Boston MA, we have built the world’s first, and by far the most advanced, AI platform that is able to untangle the enormous complexity of RNA biology and find the best targets, mechanisms, and molecules.   The thesis here at Deep Genomics is that everyone, at some point in their life, will face a genetic condition, whether Mendelian or complex, and we aim to be there for them with a genetically precise therapy. We take immense pride in our team of people whose backgrounds span a diverse range of disciplines includin